A detailed history of Aptus Capital Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 38,143 shares of VKTX stock, worth $2.63 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
38,143
Previous 28,444 34.1%
Holding current value
$2.63 Million
Previous $1.51 Million 60.19%
% of portfolio
0.04%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$49.84 - $70.47 $483,398 - $683,488
9,699 Added 34.1%
38,143 $2.41 Million
Q2 2024

Jul 31, 2024

BUY
$47.39 - $80.2 $1.35 Million - $2.28 Million
28,444 New
28,444 $1.51 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.